|Videos|May 19, 2020

New Normals of Outpatient Care in a Post-COVID Society

Monica V. Mahoney, PharmD, BCPS AQ-ID, BCIDP chats with assistant editor Grant M. Gallagher on the evolving nature of outpatient infectious disease care in light of the COVID-19 pandemic.

Segment Description: Dr. Monica V. Mahoney (PharmD, BCPS AQ-ID, BCIDP) chats with assistant editor Grant M. Gallagher on the evolving nature of outpatient infectious disease care in light of the COVID-19 pandemic. Dr. Mahoney is a Clinical Pharmacy Specialist at Beth Israel Deaconess Medical Center.

More with Dr. Mahoney: Monica V. Mahoney shares an anti-microbial stewardship #StewardTip:

"Antimicrobial stewardship doesn't just end with the workday! It extends well beyond into every day practice. We can have a profound impact by educating our family and friends to avoid unnecessary antibiotics in everyday, casual conversation. Especially now, we can educate that antibiotics have no role in viral infections. Just the other day, I talked my brother out of filling a levofloxacin prescription for the tail end of the flu, because he still 'wasn't better.' A few more days of rest and he was on his way to recovery, sans antibiotic."


Related to this article

Measles Update: November 13, 2026
The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.
The Prospective Emergence of XDR Shigella Beyond High-Risk Groups
Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.